Compare ZNTL & USDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZNTL | USDE |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.1M | 146.1M |
| IPO Year | 2020 | 2026 |
| Metric | ZNTL | USDE |
|---|---|---|
| Price | $1.37 | $4.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $7.44 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 982.2K |
| Earning Date | 11-09-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.28 | $1.33 |
| 52 Week High | $6.95 | $17.50 |
| Indicator | ZNTL | USDE |
|---|---|---|
| Relative Strength Index (RSI) | 22.22 | 30.24 |
| Support Level | N/A | $1.33 |
| Resistance Level | $1.98 | $9.02 |
| Average True Range (ATR) | 0.18 | 0.77 |
| MACD | -0.01 | -0.25 |
| Stochastic Oscillator | 0.72 | 5.55 |
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
StableCoinX Inc is a newly-formed validator and infrastructure business expected to operate infrastructure and staking services, running validators and related technical services for the Ethena protocol. The company is expected to adopt a multi-year treasury strategy to build a reserve of ENA, the Ethena protocol's native token.